Abdo Haddad

735 total citations
41 papers, 434 citations indexed

About

Abdo Haddad is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Abdo Haddad has authored 41 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Surgery. Recurrent topics in Abdo Haddad's work include Venous Thromboembolism Diagnosis and Management (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Abdo Haddad is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Abdo Haddad collaborates with scholars based in United States, Canada and Japan. Abdo Haddad's co-authors include Hamed Daw, Timothy Spiro, Mellar P. Davis, Ruth Lagman, Jaroslaw P. Maciejewski, Karl S. Theil, Xuefei Jia, Tariq Kewan, Mandeep Randhawa and Manmeet S. Ahluwalia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Cancer.

In The Last Decade

Abdo Haddad

35 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdo Haddad United States 13 143 107 106 94 83 41 434
Yuan‐Bin Yu Taiwan 12 102 0.7× 40 0.4× 49 0.5× 50 0.5× 154 1.9× 35 458
Tiziana Spatola Italy 10 48 0.3× 44 0.4× 61 0.6× 57 0.6× 89 1.1× 12 423
David J. Reeves United States 14 171 1.2× 187 1.7× 46 0.4× 50 0.5× 25 0.3× 38 461
Wojciech Sydor Poland 8 31 0.2× 85 0.8× 119 1.1× 122 1.3× 76 0.9× 25 433
Hidetaka Ushigome Japan 15 43 0.3× 175 1.6× 89 0.8× 203 2.2× 66 0.8× 69 683
Kimberly Dinh United States 8 142 1.0× 70 0.7× 64 0.6× 34 0.4× 43 0.5× 15 343
Süleyman Baldane Türkiye 13 82 0.6× 63 0.6× 21 0.2× 55 0.6× 78 0.9× 49 465
K. Rodriguez-Castro Italy 15 84 0.6× 38 0.4× 42 0.4× 396 4.2× 54 0.7× 28 970
Rachel M. Pearce United Kingdom 14 187 1.3× 76 0.7× 198 1.9× 81 0.9× 430 5.2× 25 993
Ingibjörg Jóna Guðmundsdóttir Iceland 15 63 0.4× 66 0.6× 105 1.0× 241 2.6× 41 0.5× 31 526

Countries citing papers authored by Abdo Haddad

Since Specialization
Citations

This map shows the geographic impact of Abdo Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdo Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdo Haddad more than expected).

Fields of papers citing papers by Abdo Haddad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdo Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdo Haddad. The network helps show where Abdo Haddad may publish in the future.

Co-authorship network of co-authors of Abdo Haddad

This figure shows the co-authorship network connecting the top 25 collaborators of Abdo Haddad. A scholar is included among the top collaborators of Abdo Haddad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdo Haddad. Abdo Haddad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thapa, Bicky, Xuefei Jia, Hamed Daw, et al.. (2022). Metaplastic Breast Cancer: Characteristics and Survival Outcomes. Cureus. 14(8). e28551–e28551. 14 indexed citations
3.
Haddad, Abdo, et al.. (2022). Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes. Translational Andrology and Urology. 11(6). 877–901. 12 indexed citations
4.
Kewan, Tariq, et al.. (2021). Prognostic impact and risk factors of cancer‐associated thrombosis events in stage‐IV cancer patients treated with immune checkpoint inhibitors. European Journal Of Haematology. 106(5). 682–688. 21 indexed citations
5.
Haddad, Abdo, et al.. (2021). A Rare Case of Emphysematous Gastritis Secondary to Chemotherapy. Cureus. 13(10). e18895–e18895. 5 indexed citations
6.
7.
McMichael, John, et al.. (2021). Factors that Minimize Curative Resection for Gallbladder Adenocarcinoma: an Analysis of Clinical Decision-Making and Survival. Journal of Gastrointestinal Surgery. 25(9). 2344–2352. 4 indexed citations
8.
Kewan, Tariq, et al.. (2020). Clinical Characteristics and Outcomes of Primary Breast Lymphoma: The Cleveland Clinic Experience. Cureus. 12(6). e8611–e8611. 2 indexed citations
9.
Kewan, Tariq, et al.. (2018). Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma. Cureus. 10(12). e3745–e3745.
10.
11.
Khalid, Sidra, et al.. (2018). Primary Splenic Diffuse Large B-Cell Lymphoma: A Rare Case of Massive Splenomegaly and Thrombocytopenia. Cureus. 10(7). e3026–e3026. 11 indexed citations
12.
Khalid, Sidra, et al.. (2018). Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience. Cureus. 10(5). e2701–e2701. 18 indexed citations
13.
Shapiro, Marc A., James Stevenson, Nathan A. Pennell, et al.. (2015). Impact of a Stage IV NSCLC care pathway on front-line (FL) and maintenance (M) chemotherapy use at the Cleveland Clinic Taussig Cancer Institute (TCI).. Journal of Clinical Oncology. 33(15_suppl). 6609–6609. 1 indexed citations
14.
Budd, G. Thomas, Mandeep Randhawa, Manmeet S. Ahluwalia, et al.. (2014). Primary Cardiac Sarcoma. American Journal of Clinical Oncology. 39(6). 593–599. 83 indexed citations
15.
Daw, Hamed, et al.. (2013). Gene Expression Profiling for Early-stage NSCLC. American Journal of Clinical Oncology. 38(1). 103–107. 12 indexed citations
16.
Daw, Hamed, et al.. (2012). Targeted therapy for lung cancer. Anti-Cancer Drugs. 23(10). 1016–1021. 23 indexed citations
17.
Haddad, Abdo & Dale R. Shepard. (2011). Geriatric Oncology and Palliative Medicine. Seminars in Oncology. 38(3). 362–366. 5 indexed citations
18.
Yavuzşen, Tuğba, Declan Walsh, Mellar P. Davis, et al.. (2009). Components of the anorexia–cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Supportive Care in Cancer. 17(12). 1531–1541. 28 indexed citations
19.
Gondek, Lukasz P., Abdo Haddad, Christine L. O’Keefe, et al.. (2007). Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes. Experimental Hematology. 35(11). 1728–1738. 39 indexed citations
20.
Haddad, Abdo, Mellar P. Davis, & Ruth Lagman. (2006). The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions. Supportive Care in Cancer. 15(3). 251–257. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan‐Bin Yu Breakdown of academic impact, for papers by Tiziana Spatola Breakdown of academic impact, for papers by David J. Reeves Breakdown of academic impact, for papers by Wojciech Sydor Breakdown of academic impact, for papers by Hidetaka Ushigome Breakdown of academic impact, for papers by Kimberly Dinh Breakdown of academic impact, for papers by Süleyman Baldane Breakdown of academic impact, for papers by K. Rodriguez-Castro Breakdown of academic impact, for papers by Rachel M. Pearce Breakdown of academic impact, for papers by Ingibjörg Jóna Guðmundsdóttir
Rankless by CCL
2026